No takes yet. Share an insight, caveat, or question.
Translational study reveals vitamin D–induced cathelicidin drives macrophage cytotoxicity against high-grade B cell lymphoma, indicating a pathway to enhance rituximab efficacy.
Bruns et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: